Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

0.3201
Delayed Data
As of Feb 08
 -0.0449 / -12.30%
Today’s Change
0.30
Today|||52-Week Range
2.13
-35.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues247.0K512.0K296.0K715.0K
 
 
 
 
 
Depreciation And Amortization59.0K52.0K50.0K55.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses6.0M5.8M3.9M4.1M
 
 
 
 
 
Research And Development4.4M4.3M2.5M2.8M
 
 
 
 
 
Total Operating Expenses6.0M5.8M3.9M4.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.8M-5.3M-3.6M-3.4M
 
 
 
 
 
Extraordinary Charge-227.0K-20.0K-4.0K-27.0K
 
 
 
 
 
Other Expenses101.0K-358.0K-133.0K232.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.9M-5.7M-3.8M-3.2M
 
 
 
 
 
Income Taxes-1.1M-763.0K-405.0K-478.0K
 
 
 
 
 
Preferred Dividend-50.0K-50.0K-50.0K-50.0K
 
 
 
 
 
Net Income-4.8M-4.9M-3.3M-2.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.0M26.1M34.4M34.7M
 
 
 
 
 
Shares To Calculate EPS Diluted23.0M26.1M34.4M34.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.21-$0.19-$0.10-$0.08
 
 
 
 
 
EPS Diluted-$0.21-$0.19-$0.10-$0.08